Filing Flows

Filing Flows › Companies › Tecogen › Cash flow

Tecogen cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$2.4M in Q2 2026 · −$11.8M over twelve months

Operating cash flow−$2.4M
Capital spending−$73K
Free cash flow−$2.4M
Cash conversion cycle287 days

Analysis

In Q2 2026, Tecogen generated −$2.4M of operating cash flow and spent $73K on capital projects, leaving free cash flow of −$2.4M. That is $321K more than in Q2 2025 (−$2.7M).

Over the twelve months to Jun 30, 2026, operating cash flow was −$11.6M; the largest uses were operating cash flow ($11.6M), net borrowing (+) / repaid (−) ($493K), capital spending ($242K); besides operations, cash came from other financing ($17.0M), shares issued ($366K); the cash balance rose by $5.1M.

Operating cash flow was −$2.4M against net income of −$2.1M. The largest differences: receivables +$828K, inventory −$588K, payables −$543K.

Its cash conversion cycle was 287 days (receivables 73 + inventory 299 − payables 85).

Free cash flow

Tecogen: free cash flow by quarterTecogen: free cash flow by quarter−$490KQ3 2024$4.0MQ4 2024−$1.3MQ1 2025−$2.7MQ2 2025−$3.6MQ3 2025−$2.6MQ4 2025−$3.2MQ1 2026−$2.4MQ2 2026
Operating cash flow less capital spending.
Tecogen: operating cash flow against capital spendingTecogen: operating cash flow against capital spendingOperating cash flowCapital spending−$207K$282KQ3 2024$4.2M$130KQ4 2024−$1.2M$132KQ1 2025−$2.6M$146KQ2 2025−$3.6M$75KQ3 2025−$2.6M$47KQ4 2025−$3.1M$46KQ1 2026−$2.4M$73KQ2 2026
Latest (Q2 2026): Operating cash flow −$2.4M, Capital spending $73K.

Capital allocation, year by year

Tecogen: where the cash came from (up) and went (down), by fiscal yearTecogen: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingAcquisitionsFY2021: Operating cash flow $465KFY2021: Net borrowing $1.9MFY2021: Asset sales $10KFY2021: Capital spending −$91K$2.3MFY2021FY2022: Operating cash flow −$1.4MFY2022: Asset sales $73KFY2022: Capital spending −$315K$73KFY2022FY2023: Operating cash flow −$818KFY2023: Net borrowing $500KFY2023: Asset sales $35KFY2023: Capital spending −$47KFY2023: Acquisitions −$170K$535KFY2023FY2024: Operating cash flow $4.1MFY2024: Net borrowing $1.9MFY2024: Shares issued $71KFY2024: Asset sales $51KFY2024: Capital spending −$969K$6.1MFY2024FY2025: Operating cash flow −$9.9MFY2025: Net borrowing −$1.4MFY2025: Shares issued $18.8MFY2025: Asset sales $4KFY2025: Capital spending −$401K$18.8MFY2025
Over these 5 years operating cash flow totalled −$7.6M; the largest uses were operating cash flow ($12.1M) and capital spending ($1.8M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$6.8M
Debtnone
Net cash$6.8M
Cash runway7 months

Tecogen is burning cash: its operations consume cash, a free cash flow of −$11.8M a year at the current rate against $6.8M of cash and investments: a runway of about 7 months before any new financing.

Where the cash came from and went

Tecogen: sources (+) and uses (−) of cash, Q2 2026Tecogen: sources (+) and uses (−) of cash, Q2 2026Cash drawn (+) / kept (−)$2.6MOperating cash flow−$2.4MNet borrowing (+) / repaid (−)−$138KCapital spending−$73KShares issued$10KOther investing$5K
Tecogen: sources (+) and uses (−) of cash, TTM to Q2 2026Tecogen: sources (+) and uses (−) of cash, TTM to Q2 2026Other financing$17.0MOperating cash flow−$11.6MCash drawn (+) / kept (−)−$5.1MNet borrowing (+) / repaid (−)−$493KShares issued$366KCapital spending−$242KOther investing$72KAsset & business sales$9K

From profit to cash

Tecogen: net income to operating cash flow, Q2 2026Tecogen: net income to operating cash flow, Q2 2026Net income−$2.1MDepreciation & amortization$279KStock-based pay$146KGains on disposals$3KReceivables$828KInventory−$588KPayables−$543KAccrued liabilities$45KPrepaid and other assets$125KOther liabilities−$224KOperating cash flow−$2.4M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 20267329985287
Q1 20266626984251
Q4 20259128193278
Q3 20258217777182
Q2 20257818488175
Q1 20257321794196
Q4 202487269124232
Q3 202488292135246

Every quarter

QuarterOperating cash flowCapital spendingNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026−$2.4M−$73K−$138K$10K$2.6M−$2.4M
Q1 2026−$3.1M−$46K−$94K$54K$3.1M−$3.2M
Q4 2025−$2.6M−$47K−$218K$38K$2.8M−$2.6M
Q3 2025−$3.6M−$75K−$43K$263K−$13.6M−$3.6M
Q2 2025−$2.6M−$146K−$24K$356K$2.4M−$2.7M
Q1 2025−$1.2M−$132K−$39K$38K$1.3M−$1.3M
Q4 2024$4.2M−$130K−$6K$71K−$4.1M$4.0M
Q3 2024−$207K−$282K−$26K—$69K−$490K

Tecogen: income statement and cash flow

Tecogen, Q2 2026: revenue $5.7M (-21% year over year), operating margin -37.4%. The chart follows the revenue to costs, profit and cash.

Tecogen: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.